Showing 4681-4690 of 7861 results for "".
- Endo International Launches New Phase 2b Study of CCH for Cellulitehttps://practicaldermatology.com/news/endo-international-launches-new-phase-2b-study-of-cch-for-cellulite/2458699/A Phase 2b study of collagenase clostridium histolyticum (CCH) for the treatment of as cellulite is about to get started, Endo International plc reports. CCH is intended to target and lyse collagen tethers with the goal of releasing the skin di
- Interferon Not Beneficial for Most Stage III Melanomahttps://practicaldermatology.com/news/interferon-not-beneficial-for-most-stage-iii-melanoma/2458703/Most stage III melanoma patients do not benefit from treatment with interferon, according to final results for the Sunbelt Melanoma Trial, published online in the Jour
- ZELTIQ® Taps Todd Zavodnick as New President, Internationalhttps://practicaldermatology.com/news/zeltiq-taps-todd-zavodnick-as-new-president-international/2458708/Todd Zavodnick is the new President, International of ZELTIQ®. Mr. Zavodnick will be responsible for driving the company’s international growth and expansion. He rec
- Novan Announces Robert A. Ingram as Chairmanhttps://practicaldermatology.com/news/novan-announces-robert-a-ingram-as-chairman/2458716/Novan, Inc. named Robert A. Ingram as Chairman of the Board of Directors of Novan. In addition, Robert Keegan has been appointed to the Board of Directors. The company also announced that it received $32.8 million of net proceeds in a private Mezzanine B financing in December 2015 from it
- Study Shows Novel Effects of Eucerin Active Ingredient Complex on Atopic Dermatitishttps://practicaldermatology.com/news/study-shows-novel-effects-of-eucerin-active-ingredient-complex-on-atopic-dermatitis/2458717/Beiersdorf researchers in collaboration with the Dermatological Clinic of the University of Lübeck have shown in a double-blind clinical study that the AtopiControl ingredient complex including licochalcone, a from the licorice root and omega-6 fatty acids from evening primros
- FDA Issues Consumer Warning about Crema Piel De Seda (Silky Skin Cream) by Viansilk: Risk of Mercury Poisoninghttps://practicaldermatology.com/news/fda-issues-consumer-warning-about-crema-piel-de-seda-silky-skin-cream-by-viansilk-risk-of-mercury-poisoning/2458725/The FDA warned consumers not to purchase or use a skin whitening cream called “Crema Piel De Seda,” due to the risk of mercury poisoning. FDA laboratory analysis identified mercury in the product. Exposure to mercury can cause serious health problems, such as kidney and nervous system
- BioPharmX Corporation Appoints Craig A. Barbarosh to its Board of Directorshttps://practicaldermatology.com/news/biopharmx-corporation-appoints-craig-a-barbarosh-to-its-board-of-directors/2458734/BioPharmX Corporation appointed Craig A. Barbarosh to its board of directors. He will serve as an independent board member on the audit and compensation committees and will chair the nominating and corporate governance committee. Mr. Barbarosh is a member of the board of directors o
- Study: Women Younger than 40 at Melanoma Diagnosis Indoor Tanned Earlier, Morehttps://practicaldermatology.com/news/study-women-younger-than-40-at-melanoma-diagnosis-indoor-tanned-earlier-more/2458731/Melanoma among younger individuals is on the rise, and now new research suggests that initiating indoor tanning at an earlier age and more frequent tanning may be to blame. In the study, women younger than 40 when diagnosed with melanoma reported initiating indoor tanning at an earlier ag
- New Web Tool May Curb Indoor Tanning Use Among Coedshttps://practicaldermatology.com/news/new-web-tool-may-curb-indoor-tanning-use-among-coeds/2458737/A web-based intervention that taps into indoor tanning users’ perceptions about the value of tanning may help curb tanning bed use among young females, suggests research out of Rutgers Cancer Institute of New Jersey in New Brunswick. Research has shown that some indoor tanners do so
- Study: MD Complete Holds Its Own Against Two Rx Skincare Regimenshttps://practicaldermatology.com/news/md-complete-holds-own-against-two-rx-skincare-regimens/2458736/A new split-face study suggests that a mass marketed skin care system can hold its own against two prescription skin care regimens when it comes to improving photoaged skin. The new findings, which compared MD Complete with two professi